CNBX
CNBX Pharmaceuticals Inc.
Key Financials
Gross Profit
$5684
↓ 94.9%
Operating Income
$-271691
↑ 53.4%
Net Income
$-313976
↑ 54.8%
Total Liabilities
$491164.00
↑ 45.2%
Shareholders' Equity
$-2496293.00
↓ 0.7%
Total Assets
$18437.00
↓ 41.3%
Cash & Equivalents
$15111.00
↓ 42.8%
Revenue
$0
↓ 100.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CNBX |
| Company Name | CNBX Pharmaceuticals Inc. |
| CIK | 1343009 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0831 |
| State of Incorporation | NV |
| Phone | 877-424-2429 |